Workflow
江中药业: 江中药业第二期限制性股票激励计划实施考核管理办法

Core Viewpoint - The implementation of the second phase of the restricted stock incentive plan aims to enhance the corporate governance structure and establish a balanced value distribution system to motivate key personnel and ensure steady performance improvement for Jiangzhong Pharmaceutical Co., Ltd [1] Group 1: Assessment Objectives and Principles - The assessment aims to improve the corporate governance structure and establish an incentive and constraint mechanism to ensure the smooth implementation of the incentive plan and achieve the company's strategic and operational goals [1] - The assessment must adhere to principles of fairness, openness, and justice, closely linking the incentive plan with the performance and contributions of the incentivized individuals to maximize the interests of the company and all shareholders [2] Group 2: Assessment Scope and Responsibilities - The assessment applies to all individuals identified in the incentive plan [2] - The Board of Directors serves as the execution management body for the plan, with the Compensation and Assessment Committee responsible for leading, organizing, and reviewing the assessment work [2] Group 3: Performance Evaluation Indicators and Standards - The performance evaluation indicators include: - A return on invested capital of no less than 15.42% for 2023, exceeding the 50th percentile of benchmark companies or the industry average [2] - A net profit growth rate of no less than 12% for 2023, based on the 2022 net profit attributable to the parent company, also exceeding the 50th percentile of benchmark companies or the industry average [2] - A research and development investment intensity of no less than 3.90% for 2023 [2] Group 4: Conditions for Granting and Lifting Restrictions - Individuals must achieve a performance assessment score of 80 or above in the previous year to be granted restricted stocks [5] - The assessment period for the incentive plan is from 2025 to 2027, with annual assessments determining the lifting of restrictions on the stocks [3][4] Group 5: Assessment Procedures and Feedback - The financial department assesses whether the annual audited performance meets the company’s performance assessment indicators [7] - Individuals have the right to know their assessment results and can appeal within five working days if they disagree with the results [7] Group 6: Additional Provisions - The Board of Directors is responsible for formulating, interpreting, and revising the assessment management measures [8] - The measures will take effect upon approval by the company's shareholders' meeting and the activation of the incentive plan [8]